Published August 1, 2025 | Version v1
Report Open

Emerging Trends and Market Growth in Precision Diagnostics through 2032

Creators

Description

Precision Diagnostics Market Analysis 2024-2032

Market Size and Growth

The global precision diagnostics market is projected to grow from $85.34 billion in 2024 to $229.27 billion by 2032, at a CAGR of 13.1%. North America leads with 37.36% market share as of 2023.

Key Market Drivers

  • Rising cancer prevalence: The National Cancer Institute projects new cancer cases will reach 29.5 million and cancer-related deaths 16.4 million annually by 2040
  • Increased demand for personalized medicine and early disease detection
  • COVID-19 impact: Accelerated adoption of precision diagnostics, with the U.S. accounting for 96.2% of North American cases in May 2021

Market Segments

By Type

  • Genetic Tests (largest segment)
  • Esoteric Tests
  • Others (direct-to-consumer tests)

By Application

  • Oncology (fastest growing)
  • Cardiovascular
  • Immunology
  • Neurology

By End User

  • Clinical Laboratories (dominant segment)
  • Hospitals
  • Homecare

Recent Developments

  • January 2024: Siemens Healthineers partnered with Indian Institute of Science to advance precision medicine through AI and machine learning
  • January 2023: Apollo Cancer Centre launched India's first Precision Oncology Centre with AI technology
  • May 2023: Bayer introduced a dedicated Precision Health business division

Regional Analysis

  • North America: Market valued at $28.34 billion in 2023, driven by established healthcare infrastructure
  • Europe: Growth fueled by technological advancements and COVID-19 impact
  • Asia Pacific: Fastest growing region, driven by rising chronic disease prevalence
  • Latin America and Middle East & Africa: Slower growth due to lower awareness and limited reimbursement policies

Key Market Players

  • Quest Diagnostics (U.S.)
  • QIAGEN (Germany)
  • Swiss Precision Diagnostics (Switzerland)
  • Koninklijke Philips N.V (Netherlands)
  • Lantheus Medical Imaging (U.S.)
  • Bluebird Bio (U.S.)

Market Challenges

  • High capital investment requirements for R&D
  • Data privacy and security concerns
  • Strict regulatory requirements
  • Need for skilled personnel to manage data and algorithms

Footnotes

Fortune Business Insights - Precision Diagnostics Market Size, Share | Growth Report [2032]

https://www.fortunebusinessinsights.com/industry-reports/precision-diagnostics-market-100357

Files

Precision Diagnostics Market Size & Share Analysis.pdf

Files (449.1 kB)